Extracorporeal Membrane Oxygenation Machines Market Size & Share, by Type (Veno-Venous, Veno-Arterial), End User (Hospitals, Specialty Clinics, Emergency Medical Services) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5525
  • Published Date: Jan 11, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Extracorporeal Membrane Oxygenation Machines Market size is expected to cross USD 30 Billion by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of extracorporeal membrane oxygenation machines was over USD 18 Billion. The increasing prevalence of respiratory disorders stands as a primary growth driver for the market. Respiratory diseases, including acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and severe pneumonia, are on the rise globally. As a result, the demand for ECMO machines, which provide vital life support to patients with compromised lung function, has witnessed a substantial surge. According to the World Health Organization (WHO), respiratory infections and chronic respiratory diseases are responsible for a significant proportion of global morbidity and mortality.

In severe cases of respiratory failure, traditional ventilator support may prove insufficient. ECMO machines play a crucial role in providing advanced respiratory assistance by oxygenating the blood outside the body, offering a vital lifeline to patients with compromised lung function. Events such as pandemics or large-scale health crises can significantly impact the ECMO market as these machines play a crucial role in supporting patients with severe respiratory distress.


Extracorporeal Membrane Oxygenation Machine Market
Get more information on this report: Request Free Sample PDF


ECMO Machines Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~7%

Base Year Market Size (2023)

~ USD 18 Billion

Forecast Year Market Size (2036)

~ USD 30 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Extracorporeal Membrane Oxygenation Machines Sector: Growth Drivers and Challenges

Market-Growth-Drivers

Growth Drivers

  • Technological Advancements Driving Innovation: Technological advancements in medical devices continue to drive innovation in extracorporeal membrane oxygenation (ECMO) machines, enhancing their efficiency, safety, and usability. Ongoing research and development efforts have led to the introduction of ECMO systems with improved features, including better oxygenation capabilities, reduced hemolysis rates, and enhanced biocompatibility. According to a report, the ECMO sales have experienced a 15% year-on-year increase in research and development investments by key industry players over the past three years, reflecting a commitment to technological advancements.
  • Global Health Events and Preparedness: Global health events, such as pandemics, underscore the critical role of ECMO machines in providing life support during emergencies. The COVID-19 pandemic highlighted the importance of advanced respiratory support systems, leading to increased awareness and preparedness efforts worldwide, thereby driving the demand for ECMO machines. In the wake of the COVID-19 pandemic, a World Health Organization (WHO) report indicates a 40% increase in the procurement of ECMO machines by healthcare institutions globally to enhance their critical care capabilities and readiness for future health crises.
  • Expansion of ECMO Application in Trauma Cases: The application of ECMO machines has expanded beyond traditional cardiac and respiratory cases to include trauma patients. ECMO therapy is increasingly recognized as a valuable tool in providing circulatory and respiratory support for trauma patients experiencing severe organ dysfunction. This expanded application broadens the market potential for ECMO machines. extracorporeal membrane oxygenation machines market is propelled by a multifaceted set of growth drivers, ranging from technological innovations to demographic shifts and strategic collaborations.

Challenges

  • High Cost of ECMO Therapy: One significant challenge is the high cost associated with ECMO therapy. The initial investment and ongoing expenses related to ECMO machines, monitoring equipment, and specialized medical personnel can strain healthcare budgets. This financial burden may limit the accessibility of ECMO therapy, particularly in regions with resource constraints. The cost barrier may impede the widespread adoption of ECMO machines, restricting their use to well-funded healthcare facilities and leading to disparities in access to advanced life support technologies. There is a lack of comprehensive awareness and training among healthcare professionals regarding the optimal utilization of ECMO therapy. As ECMO machines involve complex technology and require specialized skills for proper management, inadequate training can lead to suboptimal use and potential complications.
  • Limited Awareness and Training
  • Patient Selection and Ethical Considerations


Extracorporeal Membrane Oxygenation Machines Segmentation

Type (Veno-Venous, Veno-Arterial)

The veno-arterial segment in the extracorporeal membrane oxygenation machines market is estimated to gain the largest revenue share of 60% in the year 2036. VA ECMO has become an integral part of heart transplantation protocols, providing vital support during the critical period between organ harvesting and implantation. This use extends the viability of donor hearts, ensuring optimal conditions for successful transplantation. A comprehensive review of heart transplantation programs across multiple transplant centers indicated a 40% rise in the utilization of VA ECMO as a bridge to transplant, showcasing its significance in improving the success rates of heart transplantation procedures. The Veno-Arterial (VA) ECMO segment's growth is driven by its pivotal role in addressing cardiac emergencies, expanding indications in cardiac surgery, managing cardiogenic shock, improving survival rates, and integrating seamlessly into heart transplantation protocols.

End User (Hospitals, Specialty Clinics, Emergency Medical Services)

ECMO machines market from the hospitals segment is expected to garner a significant share in the year 2036. Government initiatives aimed at enhancing critical care infrastructure in hospitals are contributing to the growth of ECMO utilization. Increased funding for the expansion and modernization of critical care units enables hospitals to invest in advanced life support technologies, including ECMO machines. Government healthcare expenditure reports indicated a 25% year-on-year increase in funding allocated to critical care infrastructure development, signifying the prioritization of resources for advanced technologies like ECMO in hospital settings. Government initiatives aimed at enhancing critical care infrastructure in hospitals are contributing to the growth of ECMO utilization. Increased funding for the expansion and modernization of critical care units enables hospitals to invest in advanced life support technologies, including ECMO machines. The hospitals segment in the market is flourishing due to the increasing prevalence of critical cases, advancements in critical care practices, a collaborative approach, technological innovations, rising ECMO utilization for pediatric cases, and supportive government initiatives.

Our in-depth analysis of the global ECMO machines market includes the following segments:

           Type

  • Veno-Venous
  • Veno-Arterial

 

   

            End User

  • Hospitals
  • Specialty Clinics
  • Emergency Medical Services

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Extracorporeal Membrane Oxygenation Machines Industry - Regional Synopsis

APAC Market Forecast

The extracorporeal membrane oxygenation machines market in the Asia Pacific region is projected to hold the largest market share of 36% by the end of 2036. Collaborations and partnerships between international ECMO machine manufacturers and local healthcare institutions in the Asia Pacific region are promoting technology transfer. These collaborations enhance the accessibility of advanced ECMO technologies, ensuring that the region benefits from the latest developments in the field. A review of collaborative agreements in the Asia Pacific region reveals a 35% increase in partnerships between international ECMO machine manufacturers and local healthcare institutions over the past three years, facilitating the transfer of advanced ECMO technology. The market in the Asia Pacific region is further witnessing robust growth driven by factors such as the increasing incidence of respiratory diseases, a growing aging population, advancements in healthcare infrastructure, rising awareness of ECMO therapy, government initiatives for emergency preparedness, and collaborative efforts for technology transfer.

North American Market Statistics

The extracorporeal membrane oxygenation machines market in the North America region is projected to hold the second largest share during the forecast period. The North America region faces a high prevalence of cardiovascular diseases, contributing significantly to the demand for ECMO machines. Conditions such as severe heart failure and post-cardiotomy shock necessitate advanced life support, and ECMO emerges as a vital intervention in managing these critical cases. According to the American Heart Association, cardiovascular diseases account for 836,546 deaths in the United States annually, highlighting the substantial burden and underscoring the critical need for advanced cardiac support technologies like ECMO. North America is a hub for technological innovation in healthcare. The ECMO market benefits from continuous advancements, such as improved membrane materials, enhanced pump technologies, and sophisticated monitoring systems. These innovations contribute to the efficiency, safety, and overall effectiveness of ECMO therapy.

Research Nester
Extracorporeal Membrane Oxygenation Machine Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Extracorporeal Membrane Oxygenation Machines Landscape

top-features-companies
    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Getinge AB
    • LivaNova PLC
    • Terumo Corporation
    • Xenios AG
    • Microport Scientific Corporation
    • Nipro Corporation
    • ALung Technologies, Inc.
    • Sorin Group
    • Eurosets S.r.l.

In-the-news

In The News

  • Getinge expanded its surgical suite offerings by acquiring the surgical products business of ArthroCare, a US-based company specializing in orthopedic and spine surgery technologies. This strategic move enhances Getinge's presence in the growing minimally invasive surgery market and adds valuable complementary products to their portfolio.
  • Getinge introduced the UVD Robots UVC disinfection robot, designed to automate and streamline disinfection procedures in healthcare facilities. This innovation promotes hospital hygiene and aims to reduce the risk of healthcare-associated infections by utilizing targeted ultraviolet (UVC) light technology.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5525
  • Published Date: Jan 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of extracorporeal membrane oxygenation machines is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024-2036.

The major players in the market Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Xenios AG (Acquired by Fresenius Medical Care AG & Co. KGaA), Microport Scientific Corporation, and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Extracorporeal Membrane Oxygenation Machine Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying